<?xml version="1.0" encoding="UTF-8"?>
<ref id="B203">
 <label>203.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Toniati</surname>
    <given-names>P</given-names>
   </name>
   <name>
    <surname>Piva</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Cattalini</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Garrafa</surname>
    <given-names>E</given-names>
   </name>
   <name>
    <surname>Regola</surname>
    <given-names>F</given-names>
   </name>
   <name>
    <surname>Castelli</surname>
    <given-names>F</given-names>
   </name>
   <etal/>
  </person-group>. 
  <article-title>Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy</article-title>. 
  <source>Autoimmun Rev.</source> (
  <year>2020</year>) 
  <volume>19</volume>:
  <fpage>102568</fpage>. 
  <pub-id pub-id-type="doi">10.1016/j.autrev.2020.102568pagebreak</pub-id>
  <?supplied-pmid 32376398?>
  <pub-id pub-id-type="pmid">32376398</pub-id>
 </mixed-citation>
</ref>
